---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-057393"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:06:04.327695+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Iterum shareholders reject all four EGM proposals; company warns of possible wind-down

## Summary
- Shareholders voted against increasing authorized share capital (12.8M for vs 17.9M against).
- Reverse share split proposal also defeated: 13.9M for vs 16.7M against.
- Directors' allotment authority and pre-emption opt-out similarly rejected.
- Company says vote results restrict ability to raise capital, harming operations and going concern.
- Management warns of possible wind-down, bankruptcy, or liquidation; shareholders unlikely to receive distribution.

## SEC filing metadata
- accession: 0001193125-26-057393
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000119312526057393/0001193125-26-057393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000119312526057393/itrm-20260218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-057393
- JSON: https://secwatch.observer/filing/0001193125-26-057393.json
- Plain text: https://secwatch.observer/filing/0001193125-26-057393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.